Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 22 05 2021
revised: 04 10 2021
accepted: 13 10 2021
pubmed: 14 11 2021
medline: 15 12 2021
entrez: 13 11 2021
Statut: ppublish

Résumé

The aim of this study was to report the rate of additional anomalies detected exclusively at prenatal magnetic resonance imaging (MRI) in fetuses with isolated severe ventriculomegaly undergoing neurosonography. Multicenter, retrospective, cohort study involving 20 referral fetal medicine centers in Italy, United Kingdom, Spain and Denmark. Inclusion criteria were fetuses affected by isolated severe ventriculomegaly (≥15 mm), defined as ventriculomegaly with normal karyotype and no other additional central nervous system (CNS) and extra-CNS anomalies on ultrasound. In all cases, a multiplanar assessment of fetal brain as suggested by ISUOG guidelines on fetal neurosonography had been performed. The primary outcome was the rate of additional CNS anomalies detected exclusively at fetal MRI within two weeks from neurosonography. Subgroup analyses according to gestational age at MRI (<vs ≥ 24 weeks of gestation) and the laterality of ventriculomegaly (unilateral vs bilateral) were also performed. Univariate and multivariate logistic regression analysis was used to analyze the data. 187 fetuses with a prenatal diagnosis of isolated severe ventriculomegaly on neurosonography were included in the analysis. Additional structural anomalies were detected exclusively at prenatal MRI in 18.1% of cases. When considering the type of anomaly, malformations of cortical development were detected on MRI in 32.4% cases, while midline or acquired (hypoxemic/hemorrhagic) lesions were detected in 26.5% and 14.7% of cases, respectively. There was no difference in the rate of additional anomalies when stratifying the analysis according to either gestational age at MRI or laterality of the lesion. At multivariate logistic regression analysis, the presence of additional anomalies only found at MRI was significantly higher in bilateral compared versus unilateral ventriculomegaly (OR: 4.37, 95% CI 1.21-15.76; p = 0.04), while neither maternal body mass index, age, severity of ventricular dilatation, interval between ultrasound and MRI, nor gestational age at MRI were associated with the likelihood of detecting associated anomalies at MRI. The rate of associated anomalies detected exclusively at prenatal MRI in fetuses with isolated severe ventriculomegaly is lower than previously reported, but higher compared to isolated mild and moderate ventriculomegaly. Fetal MRI should be considered as a part of the prenatal assessment of fetuses presenting with isolated severe ventriculomegaly at neurosonography.

Identifiants

pubmed: 34773875
pii: S0301-2115(21)00503-0
doi: 10.1016/j.ejogrb.2021.10.014
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-110

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Daniele Di Mascio (D)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Asma Khalil (A)

Fetal Medicine Unit, Saint George's Hospital, London, United Kingdom; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, United Kingdom.

Gianluigi Pilu (G)

Unit of Obstetrics, Department of Medical and Surgical Sciences, University of Bologna, Italy.

Giuseppe Rizzo (G)

Division of Maternal and Fetal Medicine, Ospedale Cristo Re, University of Rome Tor Vergata, Rome, Italy; Department of Obstetrics and Gynecology The First I.M. Sechenov Moscow State Medical University, Moscow, Russia.

Massimo Caulo (M)

Department of Neuroscience, Imaging and Clinical Sciences, Institute for Advanced Biomedical Technologies, "G. D'Annunzio" University of Chieti, Italy.

Marco Liberati (M)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy.

Antonella Giancotti (A)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Christoph Lees (C)

Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, United Kingdom; Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Paolo Volpe (P)

Fetal Medicine Unit, Di Venere and Sarcone Hospitals, Bari, Italy.

Danilo Buca (D)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy.

Ludovica Oronzi (L)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy.

Alice D'Amico (A)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy.

Sara Tinari (S)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy.

Tamara Stampalija (T)

Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy; Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

Ilaria Fantasia (I)

Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.

Lucia Pasquini (L)

Fetal Medicine Unit, Department for Women and Children Health, AOU Careggi, Florence, Italy.

Giulia Masini (G)

Fetal Medicine Unit, Department for Women and Children Health, AOU Careggi, Florence, Italy.

Roberto Brunelli (R)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Valentina D'Ambrosio (V)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Ludovico Muzii (L)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy.

Lucia Manganaro (L)

Department of Radiology, Anatomo-Pathology and Oncology, Sapienza University of Rome, Italy.

Amanda Antonelli (A)

Department of Radiology, Anatomo-Pathology and Oncology, Sapienza University of Rome, Italy.

Giada Ercolani (G)

Department of Radiology, Anatomo-Pathology and Oncology, Sapienza University of Rome, Italy.

Sandra Ciulla (S)

Department of Radiology, Anatomo-Pathology and Oncology, Sapienza University of Rome, Italy.

Gabriele Saccone (G)

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, Federico II University of Naples, Italy.

Giuseppe Maria Maruotti (GM)

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, Federico II University of Naples, Italy.

Luigi Carbone (L)

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, Federico II University of Naples, Italy.

Fulvio Zullo (F)

Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, Federico II University of Naples, Italy.

Claudiana Olivieri (C)

Fetal Medicine Unit, Di Venere and Sarcone Hospitals, Bari, Italy.

Tullio Ghi (T)

Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Italy.

Tiziana Frusca (T)

Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Italy.

Andrea Dall'Asta (A)

Department of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, United Kingdom; Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Italy.

Silvia Visentin (S)

Department of Woman' and Child's Health, University of Padova, Padova, Italy.

Erich Cosmi (E)

Department of Woman' and Child's Health, University of Padova, Padova, Italy.

Francesco Forlani (F)

Department of Obstetrics and Gynaecology, Arnas Civico Hospital, Palermo, Italy.

Alberto Galindo (A)

Fetal Medicine Unit, Maternal and Child Health and Development Network, University Hospital 12 de Octubre, Complutense University of Madrid, Department of Obstetrics and Gynaecology, Madrid, Spain.

Cecilia Villalain (C)

Fetal Medicine Unit, Maternal and Child Health and Development Network, University Hospital 12 de Octubre, Complutense University of Madrid, Department of Obstetrics and Gynaecology, Madrid, Spain.

Ignacio Herraiz (I)

Fetal Medicine Unit, Maternal and Child Health and Development Network, University Hospital 12 de Octubre, Complutense University of Madrid, Department of Obstetrics and Gynaecology, Madrid, Spain.

Filomena Giulia Sileo (FG)

Fetal Medicine Unit, Saint George's Hospital, London, United Kingdom; Department of Biochemical, Metabolic and Neural Sciences, International Doctorate School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; Unit of Obstetrics and Gynecology, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.

Olivia Mendez Quintero (O)

Fetal Medicine Unit, Saint George's Hospital, London, United Kingdom.

Ginevra Salsi (G)

Unit of Obstetrics, Department of Medical and Surgical Sciences, University of Bologna, Italy.

Gabriella Bracalente (G)

Fetal Medicine Unit, Department of Obstetrics and Gynecology, Osp. Cà Foncello Treviso, Italy.

José Morales-Roselló (J)

Servicio de Obstetricia, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Departamento de Pediatría Obstetricia y Ginecología, Universidad de Valencia, Spain.

Gabriela Loscalzo (G)

Servicio de Obstetricia, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Departamento de Pediatría Obstetricia y Ginecología, Universidad de Valencia, Spain.

Marcella Pellegrino (M)

Department of Woman, Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Marco De Santis (M)

Department of Woman, Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Antonio Lanzone (A)

Department of Woman, Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Cecilia Parazzini (C)

Pediatric Radiology and Neuroradiology Department, Children's Hospital V. Buzzi, Università di Milano, Italy.

Mariano Lanna (M)

Fetal Therapy Unit 'Umberto Nicolini', Children's Hospital, V. Buzzi Università di Milano, Italy.

Francesca Ormitti (F)

Department of Radiology - Azienda Ospedaliera Universitaria di Parma, Italy.

Francesco Toni (F)

IRCCS Istituto delle Scienze Neurologiche UOC Neuroradiologia, Bologna, Italy.

Flora Murru (F)

Unit of Paediatric Radiology, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Italy.

Marco Di Maurizio (M)

UOC Radiodiagnostica, AOU Meyer, Florence, Italy.

Elena Trincia (E)

UOC Neuroradiologia, Osp. Cà Foncello Treviso, Italy.

Raquel Garcia (R)

Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias, Las Palmas de Gran Canaria, Spain.

Olav Bennike Bjørn Petersen (O)

Center for Fetal Medicine and Ultrasound, Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark.

Lisa Neerup (L)

Center for Fetal Medicine and Ultrasound, Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Puk Sandager (P)

Center for Fetal Medicine, Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark; Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark.

Federico Prefumo (F)

Division of Obstetrics and Gynecology, Department of Clinical and Experimental Sciences, University of Brescia, Italy.

Lorenzo Pinelli (L)

Neuroradiology Unit, Pediatric Neuroradiology Section, ASST Spedali Civili, Brescia, Italy.

Ilenia Mappa (I)

Division of Maternal and Fetal Medicine, Ospedale Cristo Re, University of Rome Tor Vergata, Rome, Italy.

Cecilia Acuti Martellucci (C)

Department of Medical Sciences, University of Ferrara, Italy.

Maria Elena Flacco (ME)

Department of Medical Sciences, University of Ferrara, Italy.

Lamberto Manzoli (L)

Department of Medical Sciences, University of Ferrara, Italy.

Ilaria Giangiordano (I)

Department of Child and Adolescent Neuropsychiatry, Local Health Unit of Avezzano-Sulmona-L'Aquila, Sulmona, Italy.

Luigi Nappi (L)

Fetal Medicine Unit, Department of Medical and Surgical Sciences, University of Foggia, Italy.

Giovanni Scambia (G)

Department of Woman, Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Vincenzo Berghella (V)

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, USA.

Francesco D'Antonio (F)

Centre for Fetal Care and High-risk Pregnancy, Department of Obstetrics and Gynecology, University of Chieti, Italy. Electronic address: francesco.dantonio@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH